|
Volumn 390, Issue 2, 2001, Pages 169-175
|
The binding energetics of first- and second-generation HIV-1 protease inhibitors: Implications for drug design
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPRENAVIR;
INDINAVIR;
KNI 764;
KYNOSTATIN 272;
NELFINAVIR;
PROTEINASE INHIBITOR;
QUINAVIR;
RITONAVIR;
SAQUINAVIR;
UNCLASSIFIED DRUG;
ARTICLE;
BINDING AFFINITY;
CALORIMETRY;
DRUG DESIGN;
DRUG PROTEIN BINDING;
DRUG STRUCTURE;
ENTHALPY;
ENTROPY;
PRIORITY JOURNAL;
THERMODYNAMICS;
VIRUS MUTANT;
VIRUS RESISTANCE;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 0035876257
PISSN: 00039861
EISSN: None
Source Type: Journal
DOI: 10.1006/abbi.2001.2333 Document Type: Article |
Times cited : (143)
|
References (24)
|